NeoGenomics Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-13 10:40:13 ET
More on NeoGenomics
- NeoGenomics: Distribution Moat In Community Oncology
- NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- NeoGenomics sees Q4 revenue of about $190M
- Seeking Alpha’s Quant Rating on NeoGenomics
Read the full article on Seeking Alpha
For further details see:
NeoGenomics Q4 2025 Earnings Preview
NeoGenomics Inc.
NASDAQ: NEO
NEO Trading
-3.17% G/L:
$8.55 Last:
330,057 Volume:
$8.49 Open:
NEO Latest News
February 25, 2026 07:05:00 am
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
NEO Stock Data
$1,500,898,492
126,282,494
0.16%
88
N/A
Medical Diagnostics & Screening
Healthcare
US
Fort Myers
